Please enable JavaScript to continue using this application.

Compare $BNTC vs $RCKT | Chartloom

Compare

$BNTC vs $RCKT

Benitec Biopharma Inc · Rocket Pharmaceuticals Inc

BNTC

Benitec Biopharma Inc

RCKT

Rocket Pharmaceuticals Inc

Compare $BNTC vs $RCKT

Comparing Benitec Biopharma Inc and Rocket Pharmaceuticals Inc

BNTCBenitec Biopharma Inc

RCKTRocket Pharmaceuticals Inc

BNTCBenitec Biopharma Inc

Market cap

$305M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-29.5%

52W performance

-37.1%

FCF yield

-5.5%

RCKTRocket Pharmaceuticals Inc

Market cap

$280M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

34.18x

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.5%

FCF yield

-61.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BNTC

RCKT

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

RCKT

Rocket Pharmaceuticals Inc

Market Cap

BNTC$305M

RCKT$280M

Enterprise Value

BNTC$125M

RCKT$76M

Price

BNTC$8.87

RCKT$2.56

P/E Ratio

BNTCN/A

RCKTN/A

P/S Ratio

BNTC4,474.96x

RCKT0.00x

EV/Sales

BNTC1,903.93x

RCKT0.00x

EV/EBITDA

BNTC0.00x

RCKT8.60x

P/B Ratio

BNTC1.77x

RCKT0.76x

P/FCF Ratio

BNTCN/A

RCKTN/A

EV/FCF

BNTC-7.50x

RCKT-0.45x

PEG Ratio

BNTCN/A

RCKTN/A

Forward P/E (NTM)

BNTCN/A

RCKTN/A

Forward P/S (NTM)

BNTCN/A

RCKT34.18x

Revenue (TTM)

BNTC$0

RCKT$0

Revenue Growth (YoY)

BNTCN/A

RCKTN/A

Forward Rev Growth

BNTC13.8%

RCKT833.4%

Gross Margin (TTM)

BNTC100.0%

RCKT0.0%

Operating Margin (TTM)

BNTC0.0%

RCKT0.0%

EBITDA Margin (TTM)

BNTC0.0%

RCKT0.0%

Net Margin (TTM)

BNTC0.0%

RCKT0.0%

FCF Margin (TTM)

BNTCN/A

RCKTN/A

Net Income (TTM)

BNTC$-33M

RCKT$-17M

FCF (TTM)

BNTC$-17M

RCKT$-171M

EPS (TTM)

BNTC$0.00

RCKT-$0.15

ROE (TTM)

BNTC-3482.0%

RCKT-576.0%

ROA (TTM)

BNTC-3411.0%

RCKT-490.0%

ROIC (TTM)

BNTC-3482.0%

RCKT-538.0%

Cash

BNTC$180M

RCKT$225M

Debt

BNTC$0

RCKT$21M

Net Cash/Debt

BNTC$180M

RCKT$203M

Current Ratio (TTM)

BNTC34.00x

RCKT9.24x

Quick Ratio (TTM)

BNTC33.70x

RCKT9.06x

Debt/Equity (TTM)

BNTC0.00x

RCKT0.06x

Debt/Assets (TTM)

BNTC0.0%

RCKT0.0%

Interest Coverage (TTM)

BNTCN/A

RCKTN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

RCKT0.00x

Beta

BNTC0.23

RCKT0.48

52W Performance

BNTC-37.1%

RCKT-24.5%

YTD Performance

BNTC-29.5%

RCKT-26.0%

% from 52W High

BNTC-47.1%

RCKT-53.0%

% from 52W Low

BNTC4.1%

RCKT5.8%

Asset Turnover (TTM)

BNTC0.01x

RCKT0.00x

FCF Yield (TTM)

BNTC-5.5%

RCKT-61.0%

Earnings Yield (TTM)

BNTC-10.7%

RCKT-6.2%

Dividend Yield (TTM)

BNTCN/A

RCKTN/A

Rule of 40

BNTC0.0

RCKT0.0

EV/GP/RG

BNTCN/A

RCKTN/A

Ticker research

View BNTC research View RCKT research

Metric	BNTC Benitec Biopharma Inc	RCKT Rocket Pharmaceuticals Inc
Market & Valuation
Market Cap	$305M	$280M
Enterprise Value	$125M	$76M
Price	$8.87	$2.56
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	8.60x
P/B Ratio	1.77x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	34.18x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	833.4%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-17M
FCF (TTM)	$-17M	$-171M
EPS (TTM)	$0.00	-$0.15
ROE (TTM)	-3482.0%	-576.0%
ROA (TTM)	-3411.0%	-490.0%
ROIC (TTM)	-3482.0%	-538.0%
Financial Health
Cash	$180M	$225M
Debt	$0	$21M
Net Cash/Debt	$180M	$203M
Current Ratio (TTM)	34.00x	9.24x
Quick Ratio (TTM)	33.70x	9.06x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.48
52W Performance	-37.1%	-24.5%
YTD Performance	-29.5%	-26.0%
% from 52W High	-47.1%	-53.0%
% from 52W Low	4.1%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-61.0%
Earnings Yield (TTM)	-10.7%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View RCKT research

Valuation

P/S Ratio

RCKT

0.00x

BNTC

4,474.96x

EV/FCF

BNTC

-7.50x

RCKT

-0.45x

Growth & revenue

Forward Revenue Growth

RCKT

833.4%

BNTC

13.8%

Profitability & performance

Gross Margin

BNTC

100.0%

RCKT

0.0%

ROE

RCKT

-576.0%

BNTC

-3482.0%

FCF Yield %

BNTC

-5.5%

RCKT

-61.0%

52-Week Performance

RCKT

-24.5%

BNTC

-37.1%

Detailed metrics comparison

BNTC

Benitec Biopharma Inc

RCKT

Rocket Pharmaceuticals Inc

Market Cap

BNTC$305M

RCKT$280M

Enterprise Value

BNTC$125M

RCKT$76M

Price

BNTC$8.87

RCKT$2.56

P/E Ratio

BNTCN/A

RCKTN/A

P/S Ratio

BNTC4,474.96x

RCKT0.00x

EV/Sales

BNTC1,903.93x

RCKT0.00x

EV/EBITDA

BNTC0.00x

RCKT8.60x

P/B Ratio

BNTC1.77x

RCKT0.76x

P/FCF Ratio

BNTCN/A

RCKTN/A

EV/FCF

BNTC-7.50x

RCKT-0.45x

PEG Ratio

BNTCN/A

RCKTN/A

Forward P/E (NTM)

BNTCN/A

RCKTN/A

Forward P/S (NTM)

BNTCN/A

RCKT34.18x

Revenue (TTM)

BNTC$0

RCKT$0

Revenue Growth (YoY)

BNTCN/A

RCKTN/A

Forward Rev Growth

BNTC13.8%

RCKT833.4%

Gross Margin (TTM)

BNTC100.0%

RCKT0.0%

Operating Margin (TTM)

BNTC0.0%

RCKT0.0%

EBITDA Margin (TTM)

BNTC0.0%

RCKT0.0%

Net Margin (TTM)

BNTC0.0%

RCKT0.0%

FCF Margin (TTM)

BNTCN/A

RCKTN/A

Net Income (TTM)

BNTC$-33M

RCKT$-17M

FCF (TTM)

BNTC$-17M

RCKT$-171M

EPS (TTM)

BNTC$0.00

RCKT-$0.15

ROE (TTM)

BNTC-3482.0%

RCKT-576.0%

ROA (TTM)

BNTC-3411.0%

RCKT-490.0%

ROIC (TTM)

BNTC-3482.0%

RCKT-538.0%

Cash

BNTC$180M

RCKT$225M

Debt

BNTC$0

RCKT$21M

Net Cash/Debt

BNTC$180M

RCKT$203M

Current Ratio (TTM)

BNTC34.00x

RCKT9.24x

Quick Ratio (TTM)

BNTC33.70x

RCKT9.06x

Debt/Equity (TTM)

BNTC0.00x

RCKT0.06x

Debt/Assets (TTM)

BNTC0.0%

RCKT0.0%

Interest Coverage (TTM)

BNTCN/A

RCKTN/A

Net Debt/EBITDA (TTM)

BNTC0.00x

RCKT0.00x

Beta

BNTC0.23

RCKT0.48

52W Performance

BNTC-37.1%

RCKT-24.5%

YTD Performance

BNTC-29.5%

RCKT-26.0%

% from 52W High

BNTC-47.1%

RCKT-53.0%

% from 52W Low

BNTC4.1%

RCKT5.8%

Asset Turnover (TTM)

BNTC0.01x

RCKT0.00x

FCF Yield (TTM)

BNTC-5.5%

RCKT-61.0%

Earnings Yield (TTM)

BNTC-10.7%

RCKT-6.2%

Dividend Yield (TTM)

BNTCN/A

RCKTN/A

Rule of 40

BNTC0.0

RCKT0.0

EV/GP/RG

BNTCN/A

RCKTN/A

Ticker research

View BNTC research View RCKT research

Metric	BNTC Benitec Biopharma Inc	RCKT Rocket Pharmaceuticals Inc
Market & Valuation
Market Cap	$305M	$280M
Enterprise Value	$125M	$76M
Price	$8.87	$2.56
P/E Ratio	N/A	N/A
P/S Ratio	4,474.96x	0.00x
EV/Sales	1,903.93x	0.00x
EV/EBITDA	0.00x	8.60x
P/B Ratio	1.77x	0.76x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-0.45x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	34.18x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	13.8%	833.4%
Profitability
Gross Margin (TTM)	100.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-33M	$-17M
FCF (TTM)	$-17M	$-171M
EPS (TTM)	$0.00	-$0.15
ROE (TTM)	-3482.0%	-576.0%
ROA (TTM)	-3411.0%	-490.0%
ROIC (TTM)	-3482.0%	-538.0%
Financial Health
Cash	$180M	$225M
Debt	$0	$21M
Net Cash/Debt	$180M	$203M
Current Ratio (TTM)	34.00x	9.24x
Quick Ratio (TTM)	33.70x	9.06x
Debt/Equity (TTM)	0.00x	0.06x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.23	0.48
52W Performance	-37.1%	-24.5%
YTD Performance	-29.5%	-26.0%
% from 52W High	-47.1%	-53.0%
% from 52W Low	4.1%	5.8%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-61.0%
Earnings Yield (TTM)	-10.7%	-6.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BNTC research	View RCKT research